gastric cancers [2] . It has recently been reported that IL-1α is produced in many human cancer cell lines, including those of bladder cancer [3] , thyroid carcinoma [4, 5] , gastric carcinoma [6] , ovarian cancer [7] , squamous cell carcinoma [8] [9] [10] , and pancreatic carcinoma [11] . We have revealed that patients with tumors stained with IL-1 antibody by immunohistochemistry showed a higher incidence of liver metastasis of gastric cancers [12] . IL-1α produced by tumor cells stimulates the proliferation or the growth of thyroid cancer [4, 5] , gastric cancer [6], ovarian cancer [7] , and colon cancer cell lines [13] , and is considered to act as a promoter of invasion or metastasis via the expression of E-selectin on vascular endothelial cells [14] or via the production of matrix metalloproteinase from the tumor cells [15] . However, it has also been reported that IL-1α inhibited the growth of cell lines in thyroid cancer [16] , breast cancer [17, 18] , and colon cancer [19] .
Introduction
Interleukin-1-alpha (IL-1α), a cytokine mainly produced by macrophages, has multiple biologic activities and plays an important role not only in the immune system [1] but also in the proliferation and metastasis of cancers. We previously reported, using stepwise logistic regression, that among various clinicopathologic characteristics, IL-1α concentration in tumors may be one of the most useful determinants of liver metastasis of centrifuged at 1800 g for 10 min. The IL-1α concentration in the supernatants was determined by enzymelinked immunosorbent assay (Biotrak IL-1α ELISA System; RPN.2140; Amersham, Buckingham shire, United Kingdom, and corrected for protein concentration, using the Lowry method, with minor modification [20] .
DNA analysis
Materials were obtained from paraffin-embedded blocks. Single-cell suspensions from these specimens were prepared according to the method of Hedley et al. [21] , with minor modification. Three 50-µm slices were prepared from the cancer tissues. After deparaffinization, the cancer tissues were minced with scissors in 0.1 M phosphate-buffered saline and centrifuged at 1800 g for 5 min, and the necrotic tissues were then excluded. The remaining tissues were incubated in 0.25% trypsin solution at 37°C for 120 min. After filtration through a 50-µm nylon mesh, the specimens were centrifuged at 400 g for 5 min. DNA staining was performed using CycleTEST (Becton Dickinson, Mountainview CA, USA). The DNA content of individual cell nuclei, at 10 000 per sample, was measured with a FACScan/CellFIT DNA System (Becton Dickinson). On the histograms, DNA diploidy was defined as a single G0/G1 peak, and aneuploidy as more than two G0/G1 peaks. Histograms with coefficients of variation of more than 8% were excluded from the study.
Statistical analysis
IL-1α concentration is expressed as picograms per milligram protein, and S-phase fractions are expressed as percentages. Any difference in the means of continuous variables between two groups was evaluated using Student's t-test or Welch's t-test.
Clinicopathologic findings were described according to the Japanese classification of gastric carcinoma proposed by the Japanese Research Society for Gastric Cancer [22] . In tumors associated with severe to moderate venous invasion (v3, v2), only IL-1α concentration showed a significantly higher level. No significant correlation was observed between IL-1α concentration or S-phase fraction and other clinicopathologic factors such as depth of invasion, lymph node metastasis, peritoneal dissemination, and lymphatic invasion (Table 1) .
Results

Relationship between clinicopathologic findings and IL-1α concentration or S-phase fraction of tumors
Relationship between IL-1α concentration and S-phase fraction and DNA ploidy pattern
When we compared the IL-1α concentration of the tumors with their S-phase fraction (%S), we found a positive correlation between these parameters (R ϭ 0.604; P Ͻ 0.0001). The average S-phase fraction was 11.0% and the average IL-1α concentration was 9.0 pg/mg protein. Tumors in four of the five patients Fig. 1 . Relationship between interleukin 1α concentration in tumor and S-phase fraction mucosa [23] . Recently, Kimura et al. [24] , using the techniques of immunohistochemical staining and insitu hybridization, revealed that IL-1α was strongly expressed not on interstitial cells but on gastric cancer cells themselves [24] . However, the relationship between IL-1α expression and tumor malignancy, which is estimated by tumor growth capacity, is still unclear, particularly from the viewpoint of clinical evaluation.
Here, we have demonstrated that the percentage of S-phase fraction, one of the most reliable markers of tumor growth capacity, is well correlated with IL-1α concentration. Tumors with a high percentage of Sphase fraction and a high concentration of IL-1α were associated with differentiated histology, scanty stroma, and expanding tumor growth. Ikeguchi et al. [25] reported that the mean size of the S-phase fraction a According to the Japanese classification of gastric carcinoma of the Japanese Research Society for Gastric Cancer [22] with liver metastasis had higher than average values for both parameters and a histology of differentiated type. The one remaining patient had values below the averages for both parameters; this tumor was of the undifferentiated type (Fig. 1) . There was no relationship between IL-1α concentration and DNA ploidy pattern.
Discussion
We previously reported that, for gastric cancer, IL-1α concentration in tumor tissue was significantly correlated with liver metastasis [2] . In gastric cancer patients, the IL-1α concentration in the tumor tissue has been reported to be higher than that in the normal gastric in carcinomas in differentiated tumors was significantly higher than that in tumors of the undifferentiated type. With regard to undifferentiated type tumors, an abundance of non-proliferative cells having plenty of mucin was found, which would explain why the S-phase fraction in differentiated type tumors is significantly higher than that in undifferentiated type tumors. Our study has revealed that IL-1α is one of the growth stimulators for gastric cancer. The tumorpromoting mechanism of IL-1α has been ascribed to its stimulatory effect on tumor cell proliferation through a Ca 2ϩ /calmodulin-dependent pathway, which has been demonstrated in a thyroid cancer cell line [4] , or through an epidermal growth factor (EGF) receptordependent pathway, which has been demonstrated in malignant cervical epithelial cells [26] . The EGF/ transforming growth factor-α (TGFα) receptor system may be involved in the growth modulation exerted by IL-1α in gastric cancer [6] . IL-1α has also been reported to act as an autocrine growth stimulator for an ovarian cancer cell line [7] . Recently, cyclooxygenase-2 (COX-2), which is increased by stimulation with IL-1, was shown to play an important role in the progression of gastric cancer [27] . Stimulation of tumor growth may not be the only mechanism through which IL-1α promotes cancer metastasis. IL-1α has been reported to induce the expression of urokinase-type plasminogen activator [28] , matrix metalloproteinase-9 [15] , vascular endothelial growth factor [29] , and thymidine phosphorylase [30] , all of which have the ability to promote cancer metastasis.
In conclusion, a clearly positive relationship was found between the concentration of tumor IL-1α and Sphase fraction. Given this relationship, IL-1α may be one of the growth stimulators of gastric cancer cells.
